ADMINISTRATION SITE URTICARIA

This adverse event was reported 32 times

ADMINISTRATION SITE URTICARIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LIDOCAINE, PRILOCAINE 1 0.0050
1 LEVONORGESTREL/ETHINYL ESTRADIOL 1 0.0009
2 LEBRIKIZUMAB-LBKZ 1 0.0004
3 ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS) 1 0.0004
4 HUMAN IMMUNOGLOBULIN G 7 0.0003
5 TRALOKINUMAB-LDRM 2 0.0003
6 EDOXABAN TOSYLATE 1 0.0001
7 ZONISAMIDE 1 0.0001
8 EMICIZUMAB 1 0.0001
9 TEDUGLUTIDE 1 0.0001
See all drugs enriched for association with ADMINISTRATION SITE URTICARIA